Doloket tablets are recommended for short-term use only (up to 7 days) and are not recommended for chronic use. 10 mg every 4 to 6 hours as required. Doses exceeding 40 mg per day are not recommended. For patients receiving parenteral Ketorolac Tromethamine, and who are converted to Ketorolac Tromethamine oral tablets, the total combined daily dose should not exceed 90 mg (60 mg for the elderly, renally impaired patients and patients less than 50 kg) and the oral component should not exceed 40 mg on the day the change of formulation is made. Injection: The recommended initial dose of Ketorolac is 10 mg, followed by 10 to 30 mg every four to six hours as required. A total daily dose of Ketorolac is 90 mg for non-elderly and 60 mg for the elderly, renally-impaired patients and patients less than 50. The maximum duration of treatment should not exceed two days.